Guru Ownership Trend
Guru Analysis for Axsome Therapeutics, Inc. (AXSM)
Axsome Therapeutics, Inc. (AXSM), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q4 2025, a total of 5 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $72.94 M.
Top institutional holders include Renaissance Technologies (RenTech) and Cliff Asness.
Institutional sentiment is currently Bullish. This is evidenced by a $16.34 M net inflow during the quarter.
Recent activity highlights Ray Dalio who opened a new position. Conversely, Cliff Asness reduced exposure by 12.8%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q4 2025)
Guru Consensus (Q4 2025)
FAQs for Axsome Therapeutics, Inc. (AXSM)
Major holders include Renaissance Technologies (RenTech) ($31.05 M), Cliff Asness ($18.89 M), Chuck Royce ($17.17 M). According to the latest reported data, 5 tracked investment managers collectively hold approximately 432,878 shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $16.34 M, with 3 managers increasing positions and 2 managers reducing holdings.
During the most recent reporting period, 2 managers trimmed their positions, while 0 fully exited AXSM. The total reported sell value was $2.91 M.
Yes, 1 managers opened new positions in AXSM, and 2 increased their existing holdings. The total reported buy value was $19.25 M.